Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public
- Established
- 2000-10-16
- Employees
- 1.4K
- Market Cap
- -
- Website
- http://www.nkf-pharma.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)A Trial to Assess the Pharmacokinetic Similarity Between CHS-1420 40 mg/0.4 mL and HUMIRA® (Adalimumab) 40 mg/0.4 mL in Healthy Chinese Adult Participants Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-08-29
- Target Recruit Count
- 238
- Registration Number
- NCT07147257
- Locations
- 🇨🇳
Ethics Committee of Hopeshine-Minsheng Hospital of Xinzheng, Zhengzhou, China
News
No news found